{"SPADE_UN_13937": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13937", "Peptide Name": "4287(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),34(derived from the HIV-1 HXB2 Pol region of the viral genome)", "Source": "Synthetic construct(derived from HIV-1 Reverse Transcriptase)", "Family": "Retroviridae", "Gene": "Not found", "Sequence": "PDIVIYQYMDDLYVGSDLEI", "Sequence Length": 20, "UniProt Entry": "No entry found", "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=22 µM);inhibition of strand transfer catalyzed by integrase(IC50=54 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM);HIV-1:the level of peptide binding to HIV integrase is high.[Ref.16879966]HIV:inhibition of 3′-processing catalyzed by wild-type integrase(IC50=6±1 µM);inhibition of strand transfer catalyzed by wild-type integrase(IC50=10±1 µM);inhibition of 3′-processing catalyzed by soluble mutant integrase(IC50=28±2 µM);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=23±2 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=41±2 µM);inhibition of strand transfer catalyzed by C130S integrase(IC50=2±1 µM);inhibition of 3′-processing catalyzed by C130S integrase(IC50=20 µM);inhibition of strand transfer catalyzed by C130A integrase(IC50=5 µM).NOTE:soluble mutant,C130S,C130S integrase are mutant IN.", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry", "Binding Target": "Integrase", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C108H161N21O36S", "Mass": 2361.62, "PI": 4.05, "Net Charge": -5, "Hydrophobicity": 0.18, "Half Life": "Mammalian:>20 hourYeast:>20 hourE.coli:?", "Mechanism of action": "Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3′-end processing, strand transfer, and disintegration) and inhibit virus replication.", "Literature": [{"Title": "Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.", "Pubmed ID": "15790559", "Reference": "J Biol Chem. 2005 Jun 10;280(23)21987-96.", "Author": "Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15790559"}, {"Title": "Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.", "Pubmed ID": "16879966", "Reference": "Bioorg Med Chem Lett. 2006 Oct 1;16(19)5199-202.", "Author": "Zawahir Z, Neamati N.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16879966"}], "Frequent Amino Acids": "DIY", "Absent Amino Acids": "ACFHKNORTUW", "Basic Residues": 0, "Acidic Residues": 5, "Hydrophobic Residues": 12, "Polar Residues": 7, "Positive Residues": 0, "Negative Residues": 5, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13935", "Similarity": 1.0, "Sequence": "FRKQNPDIVIYQYMD"}, {"SPADE_ID": "SPADE_UN_13936", "Similarity": 1.0, "Sequence": "KILEPFRKQNPDIVIYQYMD"}]}}}